Niche Pharmaceutical Valuation Software Business with Low Down Payment and Royalty Revenue

This listing presents a unique opportunity to acquire a niche software business specializing in pharmaceutical valuation. The software streamlines project evaluations and portfolio analysis, offering advanced modeling techniques and customization capabilities that surpass traditional tools like Excel. While revenue has historically come from consulting services and licensing fees up to $50,000 annually, the business is currently underutilized in direct software sales, indicating immense potential for scaling. The sale includes the source code, with the current owner available for paid programming support. The business requires a low upfront investment of $25,000, with a 20% royalty on future sales, making it a low-risk entry. The seller is committed to a smooth transition, and the experienced staff are willing to remain with the new owner. The business was founded in 2020 and is located in Nevada.